Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case report
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case report ; volume:6 ; number:1 ; day:17 ; month:7 ; year:2006 ; pages:1-6 ; date:12.2006
BMC cancer ; 6, Heft 1 (17.7.2006), 1-6, 12.2006
- Urheber
-
Sprinzl, Martin F.
- Beteiligte Personen und Organisationen
-
Schimanski, Carl C.
Möhler, Markus
Schadmand-Fischer, Simin
Galle, Peter R.
Kanzler, Stephan
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-6-190
- URN
-
urn:nbn:de:1111-2016030341191
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sprinzl, Martin F.
- Schimanski, Carl C.
- Möhler, Markus
- Schadmand-Fischer, Simin
- Galle, Peter R.
- Kanzler, Stephan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Fehlende Radiosensitivierung HPV-positiver HNSCC-Zelllinien bei Inhibition des EGF Rezeptors durch Cetuximab
Curcumin synergistically enhances the efficacy of gemcitabine against gemcitabine-resistant cholangiocarcinoma via the targeting LAT2/glutamine pathway
Radiolabeling of anti-EGFR antibody, Cetuximab, overcomes the radiotherapy resistance of Cetuximab resistant head and neck cancer cells
Schwere Akne unter Therapie eines metastasierten kolorektalen Karzinoms mit monoklonalem Anti-EGF-Rezeptor-Antikörper Cetuximab (Erbitux®)
Photochemical internalization of gemcitabine is safe and effective in locally advanced inoperable cholangiocarcinoma
A case of Ménétriere´s disease treated with the monoclonal antibody cetuximab
EGF
Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma
Impact of liver fibrosis on survival of patients with intrahepatic cholangiocarcinoma receiving gemcitabine-based chemotherapy
Photochemical internalization and gemcitabine combined with first-line chemotherapy in perihilar cholangiocarcinoma: observations in three patients
Photochemical internalization and gemcitabine combined with first-line chemotherapy in perihilar cholangiocarcinoma: observations in three patients
Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy
Fehlende Radiosensitivierung HPV-positiver HNSCC-Zelllinien bei Inhibition des EGF Rezeptors durch Cetuximab
Curcumin synergistically enhances the efficacy of gemcitabine against gemcitabine-resistant cholangiocarcinoma via the targeting LAT2/glutamine pathway
Radiolabeling of anti-EGFR antibody, Cetuximab, overcomes the radiotherapy resistance of Cetuximab resistant head and neck cancer cells
Schwere Akne unter Therapie eines metastasierten kolorektalen Karzinoms mit monoklonalem Anti-EGF-Rezeptor-Antikörper Cetuximab (Erbitux®)
Photochemical internalization of gemcitabine is safe and effective in locally advanced inoperable cholangiocarcinoma
A case of Ménétriere´s disease treated with the monoclonal antibody cetuximab
EGF
Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma
Impact of liver fibrosis on survival of patients with intrahepatic cholangiocarcinoma receiving gemcitabine-based chemotherapy
Photochemical internalization and gemcitabine combined with first-line chemotherapy in perihilar cholangiocarcinoma: observations in three patients
Photochemical internalization and gemcitabine combined with first-line chemotherapy in perihilar cholangiocarcinoma: observations in three patients
Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy
Fehlende Radiosensitivierung HPV-positiver HNSCC-Zelllinien bei Inhibition des EGF Rezeptors durch Cetuximab
Curcumin synergistically enhances the efficacy of gemcitabine against gemcitabine-resistant cholangiocarcinoma via the targeting LAT2/glutamine pathway
Radiolabeling of anti-EGFR antibody, Cetuximab, overcomes the radiotherapy resistance of Cetuximab resistant head and neck cancer cells
Schwere Akne unter Therapie eines metastasierten kolorektalen Karzinoms mit monoklonalem Anti-EGF-Rezeptor-Antikörper Cetuximab (Erbitux®)
Photochemical internalization of gemcitabine is safe and effective in locally advanced inoperable cholangiocarcinoma
A case of Ménétriere´s disease treated with the monoclonal antibody cetuximab
EGF
Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma
Impact of liver fibrosis on survival of patients with intrahepatic cholangiocarcinoma receiving gemcitabine-based chemotherapy
Photochemical internalization and gemcitabine combined with first-line chemotherapy in perihilar cholangiocarcinoma: observations in three patients
Photochemical internalization and gemcitabine combined with first-line chemotherapy in perihilar cholangiocarcinoma: observations in three patients